Showing results (31-40 of 131) with videos related to
Sort By:
Pageof 14
Journal of Clinical Pharmacology|May 10, 2011
Population pharmacokinetics and exposure-response of albinterferon alfa-2bMatthew M Riggs, Timothy T Bergsma, James A Rogers, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2008
Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patientsVincent G Bain, Kelly D Kaita, Paul Marotta, et al.Antiviral Therapy|February 17, 2007
Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis CVijayan Balan, David R Nelson, Mark S Sulkowski, et al.Gastroenterology|December 11, 2020
The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic SteatohepatitisZobair M Younossi, Quentin M Anstee, Vincent Wai-Sun Wong, et al.American Journal of Physiology. Heart and Circulatory Physiology|January 11, 2011
Anthrax edema toxin has cAMP-mediated stimulatory effects and high-dose lethal toxin has depressant effects in an isolated perfused rat heart modelCaitlin W Hicks, Yan Li, Shu Okugawa, et al.Journal of Hepatology|September 6, 2015
Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirinZobair M Younossi, Maria Stepanova, Michael Estep, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 7, 2011
Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3Samir R Shah, Keyur Patel, Patrick Marcellin, et al.JHEP Reports : Innovation in Hepatology|February 11, 2020
Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitisMichael Trauner, Yevgeniy Gindin, Zhaoshi Jiang, et al.ACS Biomaterials Science & Engineering|May 28, 2026
Dose-Dependent Effects of Dihydronicotinamide Riboside on Human Engineered Skeletal Muscle DevelopmentAshwin Venkateshvaran, Swarang Sachin Pundlik, Yavanica Suresh, et al.Digestive Diseases and Sciences|September 3, 2014
Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis BNaoky C Tsai, Patrick Marcellin, Maria Buti, et al.Pageof 14